Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
53.9 USD | +0.71% |
|
+2.12% | -35.44% |
06-24 | JPMorgan Cuts Price Target on Cytokinetics to $65 From $77, Maintains Overweight Rating | MT |
06-17 | Cytokinetics Insider Sold Shares Worth $262,750, According to a Recent SEC Filing | MT |
- Stock Market
- Equities
- CYTK Stock
- News Cytokinetics, Incorporated
- MarketScreener Strategies